IMSPEX NEWS

PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics. 15th May 2024, Abercynon, Wales – Imspex announces the sale of its German subsidiary, GAS Dortmund GmbH, to its majority shareholder, Hanon Group (China). This positions Imspex as a standalone […]

Meet Robin Curnow

📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful work in Breathomics: “My PhD is in Breathomics which I am carrying out within the division of Immunology, Immunity to Infection and Respiratory Medicine at the University of Manchester. Breathomics […]

Meet Trenton Stewart

IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and the University of Warwick. He is based in the Biomedical Sensors Laboratory in the School of Engineering while additionally being a Warwick Medical School student. His interdisciplinary research focuses on […]

BioWales in London

Tuesday 5th March, Canary Wharf, London IMSPEX is excited to share that our Group CEO, John McKinley, will be delivering a presentation at the MediWales BioWales event in London on Tuesday 5th March, 2024! Accompanied by our Technical Director, Dr. Emma Brodrick, join us for engaging discussions on the dynamic Welsh life science sector and […]

BioWales in London Pre-Event at The Shard

We’re pleased to announce that our Group CEO John McKinley will be participating in a panel discussion at Mathys & Squire IP Firm, located at The Shard in London. 🗓️ Date: 4th March 2024🕜 Time: 1:30 – 5pm As a pre-event to BioWales in London, hosted by MediWales, this gathering promises to be an enriching opportunity to delve […]

IMSPEX Achieves New ISO Standard

We are pleased to announce that Imspex Diagnostic Ltd has achieved a significant milestone: the publication of a new ISO standard for Siloxane testing. Developed in collaboration with NPL and Innovate UK, this standard, ISO 2613-2:2023, details the analysis of natural gas and silicon content of biomethane. Work undertaken at NPL[1] in conjunction with IMSPEX […]

ONELAB Installation at the Amsterdam University Medical Center

Imspex is pleased to announce the successful installation of the Breathspec® instrument at Amsterdam University Medical Center. This achievement is part of the ONELAB project, an initiative funded by the EU Horizon program to orchestrate next-generation mobile modular laboratories for pandemic monitoring preparedness using non-invasive breath-testing. The Horizon program has seen four Breathspec® instruments installed […]

ISO Certification

Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement follows comprehensive audits of Imspex Diagnostics’ design, development, and manufacturing operations at its Abercynon headquarters in the UK. The recommendation for registration was provided by Eurofins, a prominent international certification […]

ONELAB Annual Meeting

IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the visionary collaboration. The international scientists, data and software engineers, project managers and clinical researches marked the occasion with presentations and workshops of the incredible developments undertake over the last year. […]

ONELAB Installations

Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the Educational Corporation Saitama Medical University. This achievement is part of the ONELAB project, an initiative funded by the EU Horizon program to orchestrate next-generation mobile modular laboratories for pandemic monitoring […]

Bevan Commission NHS 75 Conference

5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with our BreathSpec® V2 device. We look forward to seeing you there! Discover more at: https://www.bevancommission.org/tipping-point/

LSX World Congress 2023

3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part of the LSX World Congress 2023 Event in London. Our Technical Director Emma Brodrick will also be in attendance to discuss Imspex’s future in next generation point-of-care testing. Discover more […]